Phase II Study of Grass Pollen Allergy Vaccine BM32

NCT01538979 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Grass Pollen Allergy

Interventions

BIOLOGICAL: BM32
BIOLOGICAL: BM32
BIOLOGICAL: Placebo

Sponsor

Biomay AG